$21.96
1.507.33%
Last update: Nov 6, 4:42 PM
Fortrea Holdings Inc (FTRE) Stock Price, Quote, News & History
FTRENASDAQ
Fortrea acquires Worldwide Clinical Trials' Early Phase division for $45 million in cash to expand its clinical research network.
You can purchase shares of Fortrea Holdings (NASDAQ:FTRE) through any online brokerage.
Other companies in Fortrea Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Fortrea Holdings has a consensus price target of $21.04.
The stock price for Fortrea Holdings (NASDAQ: FTRE) is $21.96 last updated November 6, 2026 at 4:42 PM EST.
There are no upcoming dividends for Fortrea Holdings.
Fortrea Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Fortrea Holdings.
Fortrea Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma,...
